These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21629807)

  • 1. Management of an oral ingestion of transdermal fentanyl patches: a case report and literature review.
    Faust AC; Terpolilli R; Hughes DW
    Case Rep Med; 2011; 2011():495938. PubMed ID: 21629807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent respiratory depression associated with fentanyl transdermal patch gel reservoir ingestion.
    D'Orazio JL; Fischel JA
    J Emerg Med; 2012 May; 42(5):543-8. PubMed ID: 21530138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole fentanyl patch ingestion: a multi-center case series.
    Mrvos R; Feuchter AC; Katz KD; Duback-Morris LF; Brooks DE; Krenzelok EP
    J Emerg Med; 2012 May; 42(5):549-52. PubMed ID: 21683542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of oral exposure to fentanyl transdermal delivery system patches.
    Prosser JM; Jones BE; Nelson L
    J Med Toxicol; 2010 Dec; 6(4):443-7. PubMed ID: 20532845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
    Jeal W; Benfield P
    Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Accidental intoxication with unlabeled, generic transdermal fentanyl patches caused by insufficient instruction].
    Tank S; Stork K; Skibba W; Zittel S; Andresen H; Goetz AE; Beck H
    Anaesthesist; 2007 Nov; 56(11):1137-41. PubMed ID: 17846727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe nonfatal poisoning after intravenous abuse of transdermal fentanyl--a case report].
    Magdalan J
    Przegl Lek; 2009; 66(6):341-2. PubMed ID: 19788145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl.
    Kornick CA; Santiago-Palma J; Khojainova N; Primavera LH; Payne R; Manfredi PL
    Cancer; 2001 Dec; 92(12):3056-61. PubMed ID: 11753984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
    Kornick CA; Santiago-Palma J; Moryl N; Payne R; Obbens EA
    Drug Saf; 2003; 26(13):951-73. PubMed ID: 14583070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches.
    Tharp AM; Winecker RE; Winston DC
    Am J Forensic Med Pathol; 2004 Jun; 25(2):178-81. PubMed ID: 15166776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Intoxication in a Pig (
    Sredenšek J; Bošnjak M; Lampreht Tratar U; Kosjek T; Cemazar M; Kržan M; Seliškar A
    Front Vet Sci; 2020; 7():611097. PubMed ID: 33330726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Repeated improper intravenous injection of fentanyl from a transdermal system].
    Jost U; Wolter E; Böhrer H
    Dtsch Med Wochenschr; 2004 Feb; 129(7):313-4. PubMed ID: 14765330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
    Muijsers RB; Wagstaff AJ
    Drugs; 2001; 61(15):2289-307. PubMed ID: 11772140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative analgesia with parenteral opioids: does continuous delivery utilizing a transdermal opioid preparation affect analgesic efficacy or patient safety?
    Sevarino FB; Paige D; Sinatra RS; Silverman DG
    J Clin Anesth; 1997 May; 9(3):173-8. PubMed ID: 9172021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with transdermal fentanyl for the treatment of cancer pain in Germany.
    Radbruch L; Elsner F
    Keio J Med; 2004 Mar; 53(1):23-9. PubMed ID: 15096725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature.
    Jackson LD; Wortzman R; Chua D; Selby D
    J Oncol Pharm Pract; 2021 Jan; 27(1):238-243. PubMed ID: 32501183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute poisoning following ingestion of medicines: initial management. How to treat life-threatening complications and to evaluate the risk of delayed effects and psychological distress.
    Prescrire Int; 2010 Dec; 19(111):284-91. PubMed ID: 21355384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening opioid toxicity from a fentanyl patch applied to eczematous skin.
    Doris MK; Sandilands EA
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25926584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal fentanyl in deliberate overdose in pediatrics.
    Lyttle MD; Verma S; Isaac R
    Pediatr Emerg Care; 2012 May; 28(5):463-4. PubMed ID: 22561319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.